In this review, we critically summarize recent findings derived from randomized controlled trials (RCTs), observational studies and meta-analyses that have been published in the last 3 years and that included the effects of DMTs on cognitive performances among their outcomes.

Effects on cognition of DMTs in multiple sclerosis: moving beyond the prevention of inflammatory activity

Preziosa P.;Rocca M. A.;Filippi M.
2022-01-01

Abstract

In this review, we critically summarize recent findings derived from randomized controlled trials (RCTs), observational studies and meta-analyses that have been published in the last 3 years and that included the effects of DMTs on cognitive performances among their outcomes.
2022
9-ott-2021
Inglese
Springer Science and Business Media Deutschland GmbH
269
1052
1064
13
Pubblicato
Cognition
Disease modifying drugs
Multiple sclerosis
No
none
4
info:eu-repo/semantics/article
262
Preziosa, P.; Conti, L.; Rocca, M. A.; Filippi, M.
1 Contributo su Rivista::1.1.3. Articolo in Rivista - Editorial, Comment, Reply
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/121592
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 12
social impact